A clinical study to evaluate the efficacy of Dashang Guggulu and Erand Kshar in the management of Dyslipidemia

A clinical study to evaluate the efficacy of Dashang Guggulu and Erand Kshar in the management of Medo dushti W.S.R. to Dyslipidemia - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056882

Enrollment

Registered

2023-08-24

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E784- Other hyperlipidemia

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.The patients who age in between 30 – 70 years will be selected. 2.Patients with high lipid profile. 3.The patients having clinical signs and symptoms due to Dyslipidemia. 4.Patients willing for trial.

Exclusion criteria

Exclusion criteria: 1.Patients below the age of 30 years and above 70 years. 2.Patients getting medicine for major illness e.g. IDDM, malignancy, renal insufficiency. 3. Heavy drinkers and drug abusers. 4.Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
Symptoms like breathlessness, fatigue, body odour,excess sweating,thirst,hunger and weight gain will be analysed.Timepoint: 2 months	—

Secondary

Measure	Time frame
Serum cholestrol,triglycerides,LDL & VLDL level will be analysed.Timepoint: 2 weeks,4 weeks,6 weeks& 8 weeks	—

Countries

India

Contacts

Public ContactDr Seeta Rajoria

Madan Mohan Malviya Govt. Ayurved College Udaipur

sitarajoria29@gmail.com9414605849

Outcome results